HungaroTrial has been selected as the full service provider for a PhaseII. multicenter, multinational clinical trial

HungaroTrial has been selected as theĀ full service providerĀ for a Phase II. multicenter, multinational clinical trial in chronic lymphocytic leukemia indication. The medical team of our company has been involved also into the protocol finalization process and preliminary regulatory consultations. HungaroTrial will integrate and harmonize the cooperation of all involved parties of this complex oncology project.